WORCESTER, Mass., Jan. 17, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that Shreya Life Sciences Pvt. Ltd. (www.shreya.co.in), the Company's marketing and distribution licensee in India, is rolling out its marketing launch activities for Generex Oral-lyn in the Indian market. The Company previously announced on November 1, 2007 that it had received regulatory approval to sell Generex Oral-lyn in India by the Central Drugs Standard Control Organization (CDSCO), Directorate General of Health Services, Government of India.
